BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today ...
MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...
Transcranial magnetic stimulation (TMS) has proven to be a promising tool for research, diagnosis, and treatment of neurodegenerative diseases and psychiatric disorders such as depression, ...
Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...
First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results